RandolWebbHooperMD
Pulmonology • Billings, MTCritical Care Medicine
Staff Physician, Pulmonary & Critical Care Medicine
Dr. Hooper is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
801 N 29th St
Billings, MT 59101Phone+1 406-238-2500
Education & Training
Temple University HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 2019 - 2021
Drexel University College of Medicine/Hahnemann University HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 2018 - 2019
The University of Queensland Medical SchoolClass of 2014
University of KentuckyMS, Medical Sciences, 2007 - 2009- University of KentuckyBS, Biology, 2000 - 2007
- University of KentuckyBS, History, 2000 - 2006
Certifications & Licensure
ND State Medical License 2021 - 2026
MT State Medical License 2021 - 2025
WI State Medical License 2021 - 2025
WY State Medical License 2021 - 2025
PA State Medical License 2018 - 2024
LA State Medical License 2015 - 2018- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
- National Board of Physicians and Surgeons Critical Care Medicine
- National Board of Physicians and Surgeons Internal Medicine
- National Board of Physicians and Surgeons Pulmonary Disease
- American Heart AssociationACLS
Publications & Presentations
PubMed
- 12 citationsIn vitro synergy with fluconazole plus doxycycline or tigecycline against clinical Candida glabrata isolates.Randol W Hooper, Deborah S. Ashcraft, George A. Pankey
Medical Mycology. 2019-01-01 - 9 citationsAn Emerging Crisis: Vaping-Associated Pulmonary InjuryRandol W. Hooper, Jamie L. Garfield
Annals of Internal Medicine. 2020-01-07 - Vaping-Associated Pulmonary Injury.Randol W. Hooper, Jamie L. Garfield
Annals of Internal Medicine. 2020-06-16
Journal Articles
- An Emerging Crisis: Vaping-Associated Pulmonary InjuryHooper RW, Garfield JL, Annals of Internal Medicine, 10/8/2019
Abstracts/Posters
- In vitro Synergy of Tigecycline Plus Fluconazole Against Candida glabrataHooper R, Ashcraft D, Pankey G, IDSA, San Diego, 10/2015
- In Vitro Synergy of Fluconazole Plus Doxycycline against Candida glabrataHooper R, Ashcraft D, Pankey G, Abstract presented at the American Society of Microbiologists Candida Conference, New Orleans, 3/2014
Press Mentions
AMA-brokered deal secures coverage for Hahnemann residents, fellowsMarch 21st, 2020
5 Key Takeaways From Vaping CrisisMarch 21st, 2020
Temple Students and Faculty Lead Teen Outreach Program on Vaping EducationMarch 21st, 2020
Committees
- Member, Glycemic Control Task Force - Temple University Hospital
Research History
- Research Fellow - Ochsner Clinic FoundationFollowing medical school graduation I was awarded a competitive research fellowship and stipend where I completed a self-designed project on antimicrobial synergy between tigecycline and fluconazole versus Candida glabrata.2014 - 2015
Professional Memberships
- Member
- Member
- American Center for Mongolian StudiesMember
- The Ochsner JournalPeer Reviewer
External Links
- Academia.edu profilehttp://ochsner.academia.edu/RandolHooper
- ORCID Profilehttps://orcid.org/0000-0003-1146-4751
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
